Morgan Stanley Calls Sarepta Therapeutics (SRPT) a Catalyst Driven Idea: ‘We see a 85% probability of a positive outcome, with SRPT potentially up 27%-50%’

Visit StreetInsider.com at http://www.streetinsider.com/Hot+Comments/Morgan+Stanley+Calls+Sarepta+Therapeutics+%28SRPT%29+a+Catalyst+Driven+Idea%3A+%27We+see+a+85%25+probability+of+a+positive+outcome%2C+with+SRPT+potentially+up+27%25-50%25%27/23178729.html for the full story.